Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma

Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma

Adoptive cell immunotherapy has been a hot spot in tumor research in recent years. Chimeric antigen receptor T cells (CAR-T) have achieved great success in hematological tumors and have changed the current tumor treatment landscape to a certain extent. However, the application of CAR-T therapy in cl...

Full description

Bibliographic Details
Main Authors: HU Run, YAO Pei, LI Junen, GUI Renjie, DUAN Huaxin
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-12-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
chimeric antigen receptor
natural killer cells
lymphoma
immunotherapy
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0664

Similar Items

Similar Items